- This topic has 1 voice and 0 replies.
Viewing 0 reply threads
-
Posts
-
-
The U.S. Food and Drug Administration has accepted Neurocrine Biosciences’ new drug application for opicapone as a potential add-on therapy for Parkinson’s. Read more here.
What do you think about this news?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
